Pulmonary Hypertension Program | Research and Innovation

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Pulmonary Hypertension Program

Our team in the Pulmonary Hypertension Program at Boston Children's Hospital is actively involved in therapeutic trials of new therapies for pulmonary hypertension. We’ve participated in prospective trials of inhaled nitric oxide, sildenafil, bosentan and ambrisentan. Our current therapeutic trials include:

  • evaluation of a new, more efficient way of delivering inhaled iloprost
  • study of the long-term effects of sildenafil and ambrisentan

We are also exploring new ways of evaluating the lung’s blood vessels to help us better design therapy.

Boston Children’s is so much more than a hospital—it’s a community of researchers, clinicians, administrators, support staff, innovators, teachers, patients and families, all working together to make the impossible possible. ”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital
300 Longwood Avenue, Boston, MA 02115
For Patients: 617-355-6000
For Referring Providers: 844-BCH-PEDS | 844-224-7337